Literature DB >> 23411736

No cross-resistance after sequential use of romiplostim and eltrombopag in chronic immune thrombocytopenic purpura.

Giovanni D'Arena, Roberto Guariglia, Giovanna Mansueto, Maria Carmen Martorelli, Giuseppe Pietrantuono, Oreste Villani, Rosa Lerose, Pellegrino Musto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23411736     DOI： 10.1182/blood-2012-11-465575

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  7 in total

1.  Bidirectional inefficacy or intolerability of thrombopoietin receptor agonists: new data and a concise review.

Authors:  Fabian Depré; Nasra Aboud; Beate Mayer; Abdulgabar Salama
Journal:  Blood Transfus       Date:  2017-01-25       Impact factor: 3.443

2.  Reciprocal absence of cross-resistance between eltrombopag and romiplostim in two patients with refractory immune thrombocytopenic purpura.

Authors:  Laura Scaramucci; Marco Giovannini; Pasquale Niscola; Andrea Tendas; Alessio Perrotti; Paolo De Fabritiis
Journal:  Blood Transfus       Date:  2014-10       Impact factor: 3.443

3.  Treatment patterns and clinical outcomes in patients with chronic immune thrombocytopenia (ITP) switched to eltrombopag or romiplostim.

Authors:  David J Kuter; Cynthia Macahilig; Kelly M Grotzinger; Sara A Poston; Peter Feng Wang; Katie L Dawson; Melea Ward
Journal:  Int J Hematol       Date:  2015-01-14       Impact factor: 2.490

4.  Revealing eltrombopag's promotion of human megakaryopoiesis through AKT/ERK-dependent pathway activation.

Authors:  Christian A Di Buduo; Manuela Currao; Alessandro Pecci; David L Kaplan; Carlo L Balduini; Alessandra Balduini
Journal:  Haematologica       Date:  2016-08-11       Impact factor: 9.941

5.  Efficacy and safety of eltrombopag in adult refractory immune thrombocytopenia.

Authors:  Yeo-Kyeoung Kim; Seung-Sin Lee; Sung-Hoon Jeong; Jae-Sook Ahn; Deok-Hwan Yang; Je-Jung Lee; Hyeoung-Joon Kim
Journal:  Blood Res       Date:  2015-03-24

Review 6.  Thrombopoietin receptor agonists: ten years later.

Authors:  Waleed Ghanima; Nichola Cooper; Francesco Rodeghiero; Bertrand Godeau; James B Bussel
Journal:  Haematologica       Date:  2019-05-09       Impact factor: 9.941

Review 7.  Refractory primary immune thrombocytopenia (ITP): current clinical challenges and therapeutic perspectives.

Authors:  Nicola Vianelli; Giuseppe Auteri; Francesco Buccisano; Valentina Carrai; Erminia Baldacci; Cristina Clissa; Daniela Bartoletti; Gaetano Giuffrida; Domenico Magro; Elena Rivolti; Daniela Esposito; Gian Marco Podda; Francesca Palandri
Journal:  Ann Hematol       Date:  2022-02-24       Impact factor: 4.030
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.